Hypochlorite Treats Inflammation

Scientists show that the active ingredient in bleach can reduce inflammation by targeting an activator of NF-κB.

abby olena
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The investigators used Clorox.FLICKR, VOX EFXIt has long been known that extremely dilute bleach baths—0.005 percent—can be used as a successful accessory treatment for eczema, but until now, no one understood how it worked. Researchers from Stanford University have shown that hypochlorite (HOCl)—bleach’s active ingredient—effectively blocks the function of nuclear factor κB (NF-κB), which activates genes involved in inflammation and aging. Their work was published in the Journal of Clinical Investigation last week (November 15).

“Originally it was thought that bleach may serve an antimicrobial function, killing bacteria and viruses on the skin,” coauthor Thomas Leung said in a statement. “But the concentrations used in clinic are not high enough for this to be the sole reason,” he continued, “so we wondered if there could be something else going on.”

The team treated human keratinocytes with 0.005 percent HOCl and found that they were unable to activate NF-κB until 24 hours later. The researchers showed that HOCl oxidized and inactivated inhibitor of NF-κB kinase (IKK), which is necessary for NF-κB activation, both in vitro and in vivo. The researchers also put mice in a shallow HOCl bath 30 minutes before exposing them to radiation, finding that the mice that had ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • abby olena

    Abby Olena, PhD

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours